Last reviewed: 24 October 2024
Last reviewed: 24 October 2024
Understanding who is not attending screening and the barriers preventing them from participating is important when looking at ways to support engagement with the programme. The reasons for non-attendance may be complex and several factors may be at play. It is important to address these different barriers to enable everyone who’s eligible to attend screening if they want to.
Personal perception of screening
Feeling embarrassed
Worry that the procedure will be painful (especially for post-menopausal women)
Concern for sexual connotations and being perceived as promiscuous
Fear of what the test may find
Lack of awareness of the purpose of screening
Perceived low risk of cervical cancer (eg not currently sexually active or in a lesbian relationship)
Religious beliefs (eg trust in God or outcomes being “God’s will”)
Personal experience which impacts decision to attend
Lack of trust with the health system
Previous negative screening experience (eg past painful procedure)
Previous sexual assault or abuse
Negative body image issues
Gender dysphoria
Practical or access barriers such as:
Difficulty arranging an appointment at a convenient time
Intending to go but forgetting or not getting round to it
Inaccessible information due to language or mode of delivery
people aged 25–29 and those above 50
people living in areas of high deprivation
people with a learning or physical disability
ethnic minority communities – note disparity varies by ethnic minority group
people who are lesbian or bisexual
the transgender community
people with severe mental illness
There may also be other groups in your practice population that face barriers to participating in screening. Use your practice data to identify people who are not attending screening to consider strategies to support their informed participation.
Although cervical screening is a familiar procedure for primary care staff, for most people it is not a routine process. When you have the opportunity, talk about screening with your patients, making sure to discuss potential concerns and address barriers.
Impersonal patient-provider relationships have been found to be a barrier to participation in some underscreened populations. Ensure your patients feel safe, supported and able to participate, through a good rapport and ensure people feel listened to during appointments
.In addition to screening invitations, consider different options for reminding patients of their cervical screening appointment:
Consider how your target population would want to be communicated with and try to tailor communication methods to different groups. For example, younger people have been found to prefer digital information
Templates and top tips can be found in our cervical good practice guide(PDF, 1.78 MB).
The Independent Review of Adult Screening Programmes (England),(PDF) written by Professor Sir Mike Richards recommended widespread implementation of initiatives which have been shown to improve uptake. Some that can be actioned within primary care include:
sending GP endorsements in screening reminders
providing easy read information and versions in other languages
offering screening appointments in the evening or on weekends
ensuring eligible trans and non-binary people are considered within screening invitation lists
Practice staff should undertake training to ensure they’re aware of potential barriers, support they can offer to address them and how to discuss this appropriately with people.
Check your local screening data to identify whether there are any particular areas requiring improvement. You can find out what other practices in your area may be doing in case there is an opportunity to work together, or to share good practice.
To find out about system-wide recommendations which could improve screening coverage, check out our Future optimisation of cervical screening page.
Let patients know when they should expect to receive their screening results, and who to contact if they do not receive their results in the expected timeframe.
Patients and health professionals should be aware that a previous normal cervical screening test result does not rule out cancer.
Remind your patients, regardless of whether they participate in screening, their HPV status or HPV vaccination status, that they should contact a health professional if they have any symptoms or changes that are not normal for them. You could share our public information on cervical cancer symptoms.
Read more about safety netting on our webpage for healthcare professionals.
Primary care can support colposcopy attendance following primary cervical screening, by understanding patient barriers. Anxiety, work or childcare commitments, transport and forgetting the appointment have all been identified as barriers to colposcopy attendance. In addition, non-attendance is higher in more deprived areas and among younger people
.Consider how you can contact people invited for colposcopy with a text or phone call to encourage them to attend.
Cervical Screening Primary Care Good Practice Guide(PDF, 1.78 MB)
‘Should I go for cervical screening?' video for the public
GOV.UK Cervical screening: Support people who find it hard to attend
Get resources to support uptake, including information on safety netting and barriers to participation.
Read about primary human papillomavirus (HPV) testing and cervical screening coverage.
Covers extending screening intervals, self-sampling and wider quality improvements.
Judah G, et al. A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance. BMC Cancer. 2022
Wilding, S., et al. What factors are most influential in increasing cervical cancer screening attendance? An online study of UK-based women. Health Psychology and Behavioral Medicine, 2020.
Waller J, et al. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009
Chorley, A. J., et al. Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis. Psycho-Oncology. 2017
Wearn, A. & Shepherd, L. Determinants of routine cervical screening participation in underserved women: a qualitative systematic review. Psychology & Health, 39:2, 145-170, DOI: 10.1080/08870446.2022.2050230. 2024
NHS digital. Cervical Screening Programme, England - 2022-2023.
Douglas, E., et al. Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? Journal of Medical Screening. 2016
Urwin, S. et al., Factors associated with cervical screening coverage: a longitudinal analysis of English general practices from 2013 to 2022, Journal of Public Health. 2023.
Saunders CL, et al. Cervical screening attendance and cervical cancer risk among women who have sex with women. J Med Screen. 2021.
Berner, A. M., et al. Attitudes of Trans Men and Non-binary People to UK Cervical Screening. British Journal of General Practice. 2021.
Kerrison, R. S. et al., Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programme. Nature. 2023.
Huf S, et al. Behavioural text message reminders to improve participation in cervical screening: a randomized controlled trial. The Lancet. 2017.
Charlton, C. & Rodrigues, A. M. How do young women approaching screening age interpret the NHS cervical screening leaflet? A mixed methods study of identifying interpretation difficulties, barriers, facilitators, and leaflet interpretation, engagement and future screening behaviour. Health Psychol. Behav. Med. 2024
Douglas E, et al. Colposcopy attendance and deprivation: A retrospective analysis of 27,193 women in the NHS Cervical Screening Programme. Br J Cancer. 2015
You can contact our Strategic Evidence team if you have any questions or to share information with us of any further projects that could provide evidence of screening good practice.
Read news, updates and opinion, posted weekly.
Stay up-to-date with the latest cancer research information.